Results 201 to 210 of about 15,380 (223)

FOLFIRINOX beim duktalen Adenokarzinom des Pankreas

Der Onkologe, 2019
Hakan Alakus, Michael Korenkov, Fabian Kütting, Christiane Bruns   +3 more
openaire   +1 more source

FOLFIRINOX in Locally Advanced Pancreatic Cancer

Pancreas, 2012
Antonin, Levy, Cyrus, Chargari, Florence, Huguet, Lionel, Védrine, Eric, Deutsch   +4 more
openaire   +2 more sources

Operiertes Pankreaskarzinom: Modifiziertes FOLFIRINOX versus Gemcitabin

TumorDiagnostik & Therapie, 2019
openaire   +2 more sources

Kein Überlebensvorteil mit neoadjuvantem FOLFIRINOX

InFo Hämatologie + Onkologie
Alexis Wilhelm, Florian Scheufele, Helmut Friess   +2 more
openaire   +1 more source

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis

Lancet Oncology, The, 2016
Mustafa Suker, Casper H J Van Eijck, Eran Sadot   +2 more
exaly  

Adjuvante Chemotherapie mit modifiziertem FOLFIRINOX-Regime

Gastro-News, 2019
openaire   +1 more source

Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis

Journal of the National Cancer Institute, 2019
Quisette Janssen, Mustafa Suker, Berend R Beumer   +2 more
exaly  

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

Lancet Oncology, The, 2016
Andrea Wang-Gillam, Roheena Z Panni, Adetunji T Toriola   +2 more
exaly  

Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer

British Journal of Cancer, 2016
Yan-Hong Deng, Howard S Hochster, Jill Lacy   +2 more
exaly  

Modified-FOLFIRINOX in metastatic pancreatic cancer: A prospective study in Chinese population

Cancer Letters, 2017
Xiang Li, Ri-Sheng Yu, Ying Yuan
exaly